Toralgen

About

Toralgen, Inc. is a preclinical stage biopharmaceutical company based in Madison, Indiana, founded in 2017. The company specializes in developing and commercializing human therapeutics, with a focus on enhancing drug delivery systems for biologics. Toralgen's innovative poly-bile nanoparticle platform is designed to improve the oral delivery of drugs, providing protection as they pass through the digestive system and facilitating their release into circulation. The company aims to create nanopill formulations for treating metabolic and autoimmune diseases, including diabetes and autoimmune disorders. Toralgen has been involved in significant research on oral delivery systems, with publications in respected journals like Nature Bio, showcasing its commitment to advancing drug delivery technologies. The company is open to collaborations and inquiries, fostering partnerships to further its mission.